UK experts are warning that access to new weight-loss drugs could depend more on wealth than medical need. Strict NHS ...

Obesity and diabetes treatment is undergoing a revolution with the advent of GLP-1 drugs, which help manage weight, control ...

Sun Pharma highlights obesity treatment drugs as a growth driver for India's pharma industry, enhancing access to GLP-1 ...

Viking Therapeutics VKTX is one of the few companies with a late-stage obesity candidate in its pipeline. The company is ...

Good news for people on GLP-1 therapy who hate needles: Trial data out this week shows that an experimental pill developed by Eli Lilly could offer an intriguing off-ramp.

Researchers at University Hospitals and Case Western Reserve University have discovered an enzyme that appears to play a key ...

As obesity rates continue to rise, many are turning to prescription medicines like Ozempic for weight loss. But with significant side effects, accessibility and cost issues, alternatives are needed.

“OUR TAKE: 2026 will be another big year for the obesity market, with the launch of oral GLP-1s from LLY and NVO, better ...

While childhood obesity has become more common in recent years, this is a condition that is about more than just weight.

Millions of Americans long considered outside the obesity category may, in fact, face many of the same health risks.